Literature DB >> 15498777

In vivo dynamics of EBNA1-oriP interaction during latent and lytic replication of Epstein-Barr virus.

Tohru Daikoku1, Ayumi Kudoh, Masatoshi Fujita, Yutaka Sugaya, Hiroki Isomura, Tatsuya Tsurumi.   

Abstract

The Epstein-Barr virus (EBV) nuclear antigen 1 (EBNA1) is required for maintenance of the viral genome DNA during the latent phase of EBV replication but continues to be synthesized after the induction of viral productive replication. An EBV genome-wide chromatin immunoprecipitation assay revealed that EBNA1 constantly binds to oriP of the EBV genome during not only latent but also lytic infection. Although the total levels of EBNA1 proved constant throughout the latter, the levels of the oriP-bound form were increased as lytic infection proceeded. EBV productive DNA replication occurs at discrete sites in nuclei, called replication compartments, where viral replication proteins are clustered. Confocal laser microscopic analyses revealed that whereas EBNA1 was distributed broadly in nuclei as fine punctate dots during the latent phase of infection, the protein became redistributed to the viral replication compartments and localized as distinct spots within and/or nearby the compartments after the induction of lytic replication. Taking these findings into consideration, oriP regions of the EBV genome might be organized by EBNA1 into replication domains that may set up scaffolding for lytic replication and transcription.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15498777     DOI: 10.1074/jbc.M405911200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  19 in total

1.  Functions of the Epstein-Barr virus EBNA1 protein in viral reactivation and lytic infection.

Authors:  Nirojini Sivachandran; Xueqi Wang; Lori Frappier
Journal:  J Virol       Date:  2012-04-04       Impact factor: 5.103

2.  Protein array identification of substrates of the Epstein-Barr virus protein kinase BGLF4.

Authors:  Jian Zhu; Gangling Liao; Liang Shan; Jun Zhang; Mei-Ru Chen; Gary S Hayward; S Diane Hayward; Prashant Desai; Heng Zhu
Journal:  J Virol       Date:  2009-02-25       Impact factor: 5.103

3.  Live-cell imaging reveals multiple interactions between Epstein-Barr virus nuclear antigen 1 and cellular chromatin during interphase and mitosis.

Authors:  Nathalie Jourdan; Aude Jobart-Malfait; Gabriel Dos Reis; Frédérique Quignon; Tristan Piolot; Christophe Klein; Marc Tramier; Maïté Coppey-Moisan; Vincent Marechal
Journal:  J Virol       Date:  2012-02-15       Impact factor: 5.103

4.  EBP2 plays a key role in Epstein-Barr virus mitotic segregation and is regulated by aurora family kinases.

Authors:  Priya Kapoor; Brigitte D Lavoie; Lori Frappier
Journal:  Mol Cell Biol       Date:  2005-06       Impact factor: 4.272

5.  Interaction between basic residues of Epstein-Barr virus EBNA1 protein and cellular chromatin mediates viral plasmid maintenance.

Authors:  Teru Kanda; Naoki Horikoshi; Takayuki Murata; Daisuke Kawashima; Atsuko Sugimoto; Yohei Narita; Hitoshi Kurumizaka; Tatsuya Tsurumi
Journal:  J Biol Chem       Date:  2013-07-08       Impact factor: 5.157

6.  Initiation of lytic DNA replication in Epstein-Barr virus: search for a common family mechanism.

Authors:  Andrew J Rennekamp; Paul M Lieberman
Journal:  Future Virol       Date:  2010-01       Impact factor: 1.831

7.  Mitotic chromosome interactions of Epstein-Barr nuclear antigen 1 (EBNA1) and human EBNA1-binding protein 2 (EBP2).

Authors:  Vipra Kapur Nayyar; Kathy Shire; Lori Frappier
Journal:  J Cell Sci       Date:  2009-11-03       Impact factor: 5.285

8.  Homologous recombinational repair factors are recruited and loaded onto the viral DNA genome in Epstein-Barr virus replication compartments.

Authors:  Ayumi Kudoh; Satoko Iwahori; Yoshitaka Sato; Sanae Nakayama; Hiroki Isomura; Takayuki Murata; Tatsuya Tsurumi
Journal:  J Virol       Date:  2009-04-22       Impact factor: 5.103

9.  The full-length protein encoded by human cytomegalovirus gene UL117 is required for the proper maturation of viral replication compartments.

Authors:  Zhikang Qian; Baoqin Xuan; Te Tee Hong; Dong Yu
Journal:  J Virol       Date:  2008-01-23       Impact factor: 5.103

10.  Long-term transgene expression and inhibition of HIV-1 replication by a Cre/loxP-EBNA-1/oriP HIV-1-dependent ribozyme vector: Applications for HIV-1 gene therapy.

Authors:  Takashi Nagawa; Yuichiro Habu; Norihiko Matsumoto; Naoko Miyano-Kurosaki; Hiroshi Takaku
Journal:  J RNAi Gene Silencing       Date:  2006-01-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.